InspireMD Other Non-Current Liabilities 2013-2024 | NSPR
InspireMD other non-current liabilities from 2013 to 2024. Other non-current liabilities can be defined as field containing the sum of all non-current liabilities that cannot be standardized into another field as well as those that are aggregated by the company because materially, they are too small to list separately.
| InspireMD Annual Other Non-Current Liabilities (Millions of US $) |
|
|---|---|
| 2024 | $0 |
| 2023 | $0 |
| 2022 | $0 |
| 2021 | $0 |
| 2020 | $0 |
| 2019 | $0 |
| 2018 | $0 |
| 2017 | $0 |
| 2016 | $0 |
| 2015 | $0 |
| 2014 | $0 |
| 2013 | $0 |
| 2013 | $0 |
| 2012 | $0 |
| 2012 | $2 |
| 2011 | $0 |
| InspireMD Quarterly Other Non-Current Liabilities (Millions of US $) |
|
|---|---|
| 2024-12-31 | |
| 2024-09-30 | |
| 2024-06-30 | |
| 2024-03-31 | |
| 2023-12-31 | |
| 2023-09-30 | |
| 2023-06-30 | |
| 2023-03-31 | |
| 2022-12-31 | |
| 2022-09-30 | |
| 2022-06-30 | |
| 2022-03-31 | |
| 2021-12-31 | |
| 2021-09-30 | |
| 2021-06-30 | |
| 2021-03-31 | |
| 2020-12-31 | |
| 2020-09-30 | |
| 2020-06-30 | |
| 2020-03-31 | |
| 2019-12-31 | |
| 2019-09-30 | |
| 2019-06-30 | |
| 2019-03-31 | |
| 2018-12-31 | |
| 2018-09-30 | |
| 2018-06-30 | |
| 2018-03-31 | $1 |
| 2017-12-31 | |
| 2017-09-30 | |
| 2017-06-30 | |
| 2017-03-31 | |
| 2016-12-31 | |
| 2016-09-30 | |
| 2016-06-30 | $0 |
| 2016-03-31 | |
| 2015-12-31 | |
| 2015-09-30 | |
| 2015-06-30 | |
| 2015-03-31 | |
| 2014-12-31 | |
| 2014-09-30 | |
| 2014-06-30 | |
| 2014-03-31 | |
| 2013-12-31 | |
| 2013-09-30 | |
| 2013-06-30 | |
| 2013-03-31 | $2 |
| 2012-12-31 | $2 |
| 2012-09-30 | $5 |
| 2012-06-30 | $2 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.077B | $0.007B |
| InspireMD Inc. is a medical device company focusing on the development and commercialization of its proprietary stent system technology, MGuard(TM). The Company's initial products are marketed for use mainly in patients with acute coronary syndromes, notably acute myocardial infarction and saphenous vein graft coronary interventions. It focuses on applying its technology to develop additional products used for other vascular procedures, specifically carotid and peripheral procedures. InspireMD Inc. is headquartered in Tel Aviv, Israel. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $190.127B | 83.28 |
| Thermo Fisher Scientific (TMO) | United States | $153.648B | 18.58 |
| Alcon (ALC) | Switzerland | $47.347B | 31.47 |
| Edwards Lifesciences (EW) | United States | $44.043B | 28.82 |
| IDEXX Laboratories (IDXX) | United States | $38.097B | 43.78 |
| DexCom (DXCM) | United States | $31.969B | 49.41 |
| IQVIA Holdings (IQV) | United States | $25.777B | 14.17 |
| Mettler-Toledo (MTD) | United States | $22.100B | 26.28 |
| STERIS (STE) | Ireland | $21.856B | 24.99 |
| Waters (WAT) | United States | $20.170B | 28.47 |
| SONOVA HOLDING (SONVY) | Switzerland | $18.308B | 0.00 |
| Hologic (HOLX) | United States | $11.835B | 12.86 |
| Sysmex ADR (SSMXY) | Japan | $11.715B | 0.00 |
| Penumbra (PEN) | United States | $11.306B | 88.74 |
| Globus Medical (GMED) | United States | $9.687B | 22.43 |
| Masimo (MASI) | United States | $8.725B | 32.29 |
| Teleflex (TFX) | United States | $5.328B | 8.79 |
| Glaukos (GKOS) | United States | $4.983B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.125B | 21.61 |
| TransMedics (TMDX) | United States | $3.159B | 92.46 |
| PROCEPT BioRobotics (PRCT) | United States | $2.945B | 0.00 |
| Veracyte (VCYT) | United States | $2.393B | 43.04 |
| LivaNova (LIVN) | United Kingdom | $1.917B | 11.60 |
| Elekta AB (EKTAY) | Sweden | $1.889B | 16.98 |
| Nihon Kohden (NHNKY) | Japan | $1.867B | 10.21 |
| Alphatec Holdings (ATEC) | United States | $1.779B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.420B | 0.00 |
| Artivion (AORT) | United States | $1.171B | 109.68 |
| Pulse Biosciences (PLSE) | United States | $1.113B | 0.00 |
| OPKO Health (OPK) | United States | $1.015B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.991B | 5.27 |
| AxoGen (AXGN) | United States | $0.747B | 0.00 |
| SiBone (SIBN) | United States | $0.700B | 0.00 |
| IRadimed (IRMD) | United States | $0.649B | 32.92 |
| Mesa Laboratories (MLAB) | United States | $0.641B | 14.01 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.591B | 9.24 |
| RxSight (RXST) | United States | $0.567B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.520B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.492B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.471B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.464B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.392B | 0.00 |
| NeuroPace (NPCE) | United States | $0.383B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.367B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.350B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.330B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.318B | 6.74 |
| Neuronetics (STIM) | United States | $0.296B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.230B | 13.94 |
| CVRx (CVRX) | United States | $0.194B | 0.00 |
| Inogen (INGN) | United States | $0.190B | 0.00 |
| 908 Devices (MASS) | United States | $0.190B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.182B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.164B | 0.00 |
| LENSAR (LNSR) | United States | $0.163B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.146B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.145B | 0.00 |
| Accuray (ARAY) | United States | $0.134B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.130B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.126B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.107B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.099B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.098B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.085B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.080B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.070B | 10.60 |
| EnVVeno Medical (NVNO) | United States | $0.061B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.054B | 0.00 |
| Hyperfine (HYPR) | United States | $0.052B | 0.00 |
| Positron (POSC) | United States | $0.052B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.048B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.035B | 0.00 | |
| Biosig Technologies (BSGM) | United States | $0.035B | 0.00 |
| Precision Optics (POCI) | United States | $0.034B | 0.00 |
| Envoy Medical (COCH) | United States | $0.032B | 0.00 |
| Spectral AI (MDAI) | United States | $0.030B | 0.00 |
| DarioHealth (DRIO) | United States | $0.029B | 0.00 |
| NexGel (NXGL) | United States | $0.020B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.019B | 0.00 |
| PAVmed (PAVM) | United States | $0.013B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.013B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.012B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.007B | 0.00 |
| Tenon Medical (TNON) | United States | $0.007B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.007B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.007B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.006B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.005B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 15.66 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |